CT-Assessed Sarcopenia Combined with Laboratory Inflammatory Markers for Outcome Prediction in Critically Ill, Pulmonary, and Geriatric Patients: A Systematic Review and Meta-Analysis - PubMed
3 hours ago
- #Inflammatory Markers
- #Sarcopenia
- #Prognosis
- CT-assessed sarcopenia combined with inflammatory markers predicts outcomes in critically ill, pulmonary, and geriatric patients.
- Pooled odds ratio for mortality in sarcopenic vs non-sarcopenic critically ill ICU patients was 2.28 (95% CI: 1.83-2.83).
- In COVID-19 pulmonary patients, low skeletal muscle mass had a pooled OR of 5.84 for in-hospital mortality.
- CT muscle measurements inversely correlate with CRP, fibrinogen, D-dimers, and WBC count.
- Combined CT-sarcopenia and inflammatory marker models outperformed conventional scoring systems like APACHE II and SOFA.